Postsynaptic Potentiation in Mouse Motor Synapses Induced by ATP Accumulation in Synaptic Cleft

Bull Exp Biol Med. 2015 Sep;159(5):583-7. doi: 10.1007/s10517-015-3018-2. Epub 2015 Oct 14.

Abstract

In mouse motor synapses, a non-selective purinoceptor antagonist suramin increased the quantum content of endplate potentials (EPP) without changing the time course of synaptic potentials. An ectonucleotidase inhibitor ARL 67156 had no effect on the amplitude and quantum content of EPP and miniature endplate potentials (mEPP) evoked by single stimuli, but significantly prolonged their duration. Long-term high-frequency stimulation of the nerve in the presence of ARL 67156 persistently increased the amplitude and duration of EPP during the train of impulses, but did not change their quantum content. ATP-γ-S, a non-hydrolyzed ATP analogue, significantly increased the amplitudes and prolonged the rising and falling phases of EPP and mEPP. The ATP-induced postsynaptic potentiation in neuromuscular transmission can result from the increase in ATP content and its longer presence in the synaptic cleft.

Keywords: ATP; ATP-γ-S; ectonucleotidase; endplate potentials; motor synapse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / pharmacology*
  • Animals
  • Electric Stimulation
  • Mice
  • Miniature Postsynaptic Potentials / drug effects*
  • Miniature Postsynaptic Potentials / physiology
  • Motor Endplate / drug effects*
  • Motor Endplate / physiology
  • Motor Neurons / drug effects*
  • Motor Neurons / physiology
  • Nucleotidases / antagonists & inhibitors
  • Nucleotidases / metabolism
  • Postsynaptic Potential Summation / drug effects*
  • Postsynaptic Potential Summation / physiology
  • Purinergic Antagonists / pharmacology
  • Receptors, Purinergic / metabolism
  • Suramin / pharmacology
  • Synapses / drug effects
  • Synapses / physiology
  • Tissue Culture Techniques

Substances

  • 6-N,N-diethyl-beta,gamma-dibromomethylene-D-ATP
  • Purinergic Antagonists
  • Receptors, Purinergic
  • adenosine 5'-O-(3-thiotriphosphate)
  • Suramin
  • Adenosine Triphosphate
  • Nucleotidases